A5065625930- Migraine and Headache Studies
- Cardiovascular Syncope and Autonomic Disorders
- Sympathectomy and Hyperhidrosis Treatments
- Ophthalmology and Eye Disorders
- Cerebral Venous Sinus Thrombosis
- Neuroscience of respiration and sleep
- Childhood Cancer Survivors' Quality of Life
- Vestibular and auditory disorders
- Olfactory and Sensory Function Studies
- Neurosurgical Procedures and Complications
- Child Abuse and Trauma
- Traumatic Brain Injury and Neurovascular Disturbances
- Trigeminal Neuralgia and Treatments
- Maternal Mental Health During Pregnancy and Postpartum
- Neurological Complications and Syndromes
- Health Literacy and Information Accessibility
- Adolescent and Pediatric Healthcare
- Genetics and Neurodevelopmental Disorders
- Fetal and Pediatric Neurological Disorders
- Neurology and Historical Studies
- Psychosomatic Disorders and Their Treatments
- Epilepsy research and treatment
- Anesthesia and Pain Management
- Pharmaceutical industry and healthcare
- Autoimmune Neurological Disorders and Treatments
Children's Hospital of Philadelphia
2016-2025
University of Pennsylvania
2010-2025
Philadelphia University
2019-2025
Cornell University
2017-2021
University of Alabama at Birmingham
2020-2021
Mayo Clinic in Arizona
2021
The University of Texas Southwestern Medical Center
2021
Atrium Health Wake Forest Baptist
2020
University of Virginia Health System
2020
Mayo Clinic
2020
To report the clinical features of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in patients < or = 18 years old.Information was obtained by authors referring physicians. Antibodies were determined immunocytochemistry and enzyme-linked immunosorbent assay (ELISA) using HEK293 cells ectopically expressing NR1.Over an 8-month period, 81 (12 male) with anti-NMDAR identified. Thirty-two (40%) =18 old (youngest 23 months, median 14 years); 6 male. The frequency ovarian teratomas 56%...
To outline strategies for the treatment of migraine which do not require in-person visits to clinic or emergency department, and describe ways that health insurance companies can remove barriers quality care migraine.COVID-19 is a global pandemic causing widespread infections death. control spread infection we are called observe "social distancing" have been asked postpone any procedures essential. Since procedural therapies mainstay headache care, inability could negatively affect our...
Christina Szperka: Has received grant support from Pfizer and Amgen. Juliana VanderPluym: Reports speaking fees for Amgen Novartis, consulting Healint. Serena L. Orr: Receives royalties Cambridge University Press. Christopher Oakley: None. William Qubty: Irene Patniyot: Ana Marissa Lagman-Bartolome: Is on the advisory board Teva, Allergan speakers’ bureau Aralez. Cynthia Morris: Jessica Gautreaux: Speaker’s Supernus has travel funds American Academy of Neurology. M. Cristina Victorio:...
Abstract Objectives Migraine is a common disabling neurological disorder. Current acute treatments for migraine in adolescents are mostly pharmacological and may have limited effectiveness, can cause side effects, lead to medication overuse. There an unmet need effective well‐tolerated treatments. Remote electrical neuromodulation (REN) novel treatment of that stimulates upper arm peripheral nerves induce conditioned pain modulation (CPM)—an endogenous analgesic mechanism. The REN device...
Childhood neurologic disorders, as a group, include relatively common conditions such migraine (prevalence between 3% and 10.6% in children 3–15 years of age1,2), transient tic disorders (TDs) (3%),3 specifically Tourette syndrome (TS) (0.8%),3 rarer infantile spasms that may occur only about 1,200 infants each year the United States. These account for disproportionately higher number emergency department visits, intensive care admissions, deaths, costs when compared to other childhood...
Headache evaluation and treatment are believed to be influenced by race ethnicity. Specific headache diagnosis assigned in the pediatric emergency department (ED) may compound disparities. We sought investigate racial ethnic disparities diagnosis, testing, of patients with presenting ED. performed a cross-sectional analysis ED visits from 49 children's hospitals between 2016 2022 Pediatric Health Information System, an administrative database hospitalized encounters within United States....
We conducted a quality improvement initiative to implement standardized screening for anxiety among adolescents with headache and/or epilepsy receiving outpatient neurology care at quaternary health system, consistent recommendations from the American Academy of Neurology. Our SMART (Specific, Measurable, Achievable, Relevant, and Time-Based) aim was screen ≥90% established patients aged 12 years or older seen by participating professional using screener February 2024. This in follow-up 17...
Objective To describe current patterns of use nerve blocks and trigger point injections for treatment pediatric headache. Background P eripheral are often used to treat headaches in adults children, but the available studies practice data from adult headache specialists have shown wide variability diagnostic indications, sites injected, medication(s) used. The purpose this study was disorders. Methods A survey created REDCap, sent via email 82 members Pediatric Adolescent Section American...
Objective To compare clinical features in youth with continuous headache from migraine, persistent post-traumatic headache, and new daily to determine if they are similar, contrary their distinction the International Classification of Headache Disorders. Methods We pursued a single center age- sex-matched observational study comparing characteristics 150 (11 – 17 years old) headache. A diagnostic algorithm based on international classification disorders criteria was used identify those...
Objective To identify and characterize the reasons manuscripts are rejected after peer review from journal Headache . Background Numerous editorials, reviews, research have been published on topic of manuscript rejection. However, few these papers evaluate for rejection systematically. None specific to field neurology or headache medicine. Methods A retrospective analysis all submissions January 1, 2014 through December 31, 2016 was performed. Peer reviewer editor comments each were...
Abstract Objective To assess telehealth practice for headache visits in the United States. Background The rapid roll out of during COVID‐19 pandemic impacted specialists. Methods American Headache Society (AHS) members were emailed an anonymous survey (9/9/20–10/12/20) to complete if they had logged ≥2 months or 50+ via telehealth. Results Out 1348 members, 225 (16.7%) responded. Most female (59.8%; 113/189). Median age was 47 (interquartile range [IQR] 37–57) ( N = 154). majority MD/DOs...
To determine the underlying relationships between a broad range of headache-associated symptoms and how they relate to headache burden.
Abstract Objectives We used Cluster Analysis of Migraine‐associated Symptoms (CAMS) to critically evaluate current International Classification Headache Disorders‐Third Edition (ICHD‐3) migraine‐associated symptoms criteria. Background Diagnostic criteria play a central role in guiding clinical trial inclusion, and therefore available treatments. Migraine tension‐type headaches (TTH) are differentiated ICHD‐3 by many headache characteristics, including associated symptoms. A diagnosis...
Headache is the most frequent reason for a person to seek care from neurologist and common subspecialty practice focus identified by neurologists.1 Although headache commonly encountered in primary care,2,3 it also fourth leading cause of emergency department visits,4 with 1.2 million encounters annually US departments migraine alone.5